The Professional Poster session is an opportunity to present your research to a diverse group of professionals who attend the DIA EuroMeeting.
Professional individuals from all fields related to the mission of DIA are invited to submit a poster for the EuroMeeting 2014 in Vienna.
The student poster programme is an opportunity for you to present your research results to a diverse group of scientific professionals who are actively involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and healthcare related issues.
Full-time undergraduate students are invited to submit poster abstracts.
Download Poster Guidelines [PDF]
Accepted Student Poster Abstracts
SP1: Ana Begic, Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia
Biomedical potential of Stevia - Stevia rebaudiana (Bert.) Bertoni
SP2: Charlotte Benoit, Samer Bounni, Université Claude Bernard Lyon 1, France
ACE-inhibitors for the prevention of sudden cardiac death: a meta-analysis of randomised
SP3: Pauline Blanchard, Vanessa Ville, Claude Bernard University, France,
Incidence of hypersensitivity reactions (HSR) to oxaliplatin (OP), identification and meta-analysis of potential risk factors.
SP4: Jessica Bonnefoy Isabelle Delfour, Gwenaelle Denis, Eudipharm, France
Designs for Phase I clinical trials in pediatrics. Comparison of methodologies to determine the efficacious dose.
SP5: Katarina Iric, Faculty of Pharmacy, Serbia
Testing the impact of modified reformatsky reaction on the synthesis of 3,3-bis-(4-chlorophenyl)-3-hydroxypropionic acid.
SP6: Monica Luca, University of Medicine and Pharmacy Carol Davila Bucharest, Romania
Evaluation of the non-clinical action of alpha-lipoic acid on Vincristine- and Paclitaxel-induced neuropathic pain.
SP7: Alexia Malriq, Hospices Civil De Lyon, University of Lyon, France,
Clinical Trial Data Sharing: Public access to clinical trials data on medicinal products is coming soon
SP8: Florence Margraff, Hospices Civil De Lyon, University of Lyon, France.
Adverse drug reaction reporting by patients in fifty countries.
SP9: Monika Mironiuk, Medical University of Gdansk, Poland.
Plasma non-targeted metabolic fingerprinting as a potential prognostic tool for drug-resistant hypertension.
SP10: Julie Mouchet, Lucile Penaud, Université Claude Bernard Lyon I, France
Is there a publication bias for studies assessing the benefit of fatty acids in attention deficit hyperactivity disorder?
SP11: Isabelle Rodrigues, University of Lisbon, Portugal
Ibuprofen promotes age-related bradikinin but not the acethylcholine - induced rat ileal contractility.
SP12: Maidah Sheikh, University of Vienna, Austria
The organic anion transporting polypeptide OATP4A1 may be a target for immunomodulation in early colorectal cancer.
SP13: Indre Šveikauskaite, Lithuanian University of Health Sciences, Lithuania
Differences of lead and nickel ions effects on total protein and metallothioneins synthesis in mice liver.
SP14: Birce Didar Tut, Istanbul University, Turkey
Assessment of risk management approaches in orphan drugs.
We are no longer accepting student poster abstracts.
Did you know? DIA's President (2012/2013) Ling Su began his involvement with DIA as a student poster presenter.